Ultragenyx to Acquire Dimension Therapeutics for $5.50 Per Share in Cash

Ambrogio Visconti

Centerview Partners LLC is serving as financial advisor to Ultragenyx, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as Ultragenyx’s legal advisor. Ultragenyx Pharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now